Pfizer gets USFDA nod for biosimilar to Rituximab Medical Dialogues Bureau25 July 2019 3:29 AM GMTRuxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria Farhat Nasim12 March 2019 6:31 AM GMTHydroxychloroquine tablet is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other...
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients Medical Dialogues Bureau12 May 2018 6:30 AM GMTThe U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
